Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
247.00    0.00 (0.00%)
Bid:
221.00
Ask:
0.00
Spread: 28.50 (12.896%)
Market Cap: £144.09m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Trading Update

14 Nov 2025 07:00

RNS Number : 5116H
MJ Gleeson PLC
14 November 2025
 

MJ Gleeson plc  (GLE.L)

 

AGM Trading Update

14 November 2025

MJ Gleeson plc, the low-cost housebuilder and land promoter, is issuing the following update ahead of its Annual General Meeting which is being held later today.

Gleeson Homes

Gleeson Homes' open market net reservation rates for the eight weeks to 7 November 2025, increased by 22% to 0.50 per site per week (0.92 including bulk reservations), from the 0.41 per site (0.46 including bulk reservations) during the same period last year.

Demand for new homes remains subdued, but steady, with buyers lacking confidence in the current economic environment.

Resource-constrained local planning continues to impede progress on opening new sites. Notwithstanding these challenges, since the start of the 2026 financial year, Gleeson Homes has opened six new build sites (Four months to 31 October 2024: six sites) and five new sites have commenced sales (Four months to 31 October 2024: seven sites). Gleeson Homes is currently selling on 59 sites (31 October 2024: 64 sites).

Gleeson Land

Gleeson Land is making good progress, having completed the sale of two small sites since the start of the financial year. As communicated at the time of the 2025 full year results, one site which represents approximately 50% of total plots budgeted to be sold during the year remains dependent on the finalisation of a technical solution.

The division is on track with its growth plans and making good progress towards its aim of submitting 18 planning applications in the first half of this financial year.

The Board, whilst mindful that the Government's Autumn Budget will be announced on 26 November 2025, expects that the results for the financial year ended 30 June 2026 will be in line with current market expectations1.

A trading update for the six months to 31 December 2025 will be issued on 16 January 2026 and the results for the period will be issued on 11 February 2026.

 

1 Analyst consensus for FY2026 can be found at: https://www.mjgleesonplc.com/investors/analyst-coverage/

 

 

For the purposes of UK MAR, the person responsible for arranging for the release of this information on behalf of MJ Gleeson plc is Stefan Allanson, Chief Financial Officer

LEI: 21380064K7N2W7FD6434

 

About MJ Gleeson plc

MJ Gleeson plc comprises two divisions: Gleeson Homes and Gleeson Land.

Gleeson Homes, under the banner of "Building Homes. Changing Lives" builds high-quality affordable homes across the Midlands and North of England. To meet customer demand, and without compromising affordability, the range of homes available extends from one-bed apartments to five-bedroom houses. With a two-bedroom home available from £100,000, a key objective is to ensure that on all of our developments, a meaningful proportion of homes are affordable to a couple earning the National Living Wage. Buying a Gleeson home typically costs less than renting a similar property. All Gleeson homes are traditional brick built semi or detached homes.

As a high-quality, affordable housebuilder, Gleeson has strong and inherent sustainability credentials. Its social purpose underpins the Company's strategy and Gleeson measures itself closely against UN SDGs 5, 8, 11, 12, 13 and 15. More details on the Company's approach to sustainability can be found at: www.mjgleesonplc.com/sustainability.

Gleeson Land, which operates under the banner of 'Promoting Land. Unlocking Value' is the Group's land promotion division operating in the South, West and Central England. Gleeson Land identifies development opportunities and works with landowners and stakeholders to both enhance the value of the property and to promote land through the residential planning system, ultimately managing the sale of these sites to other developers on behalf of landowners.

 

Enquiries:

 

MJ Gleeson plc

 +44 1142 612 900

Graham Prothero Chief Executive Officer

Stefan Allanson Chief Financial Officer

Invicomm (Financial PR)

mjgleeson@invicomm.com

Mark Garraway

+44 7771 860938

Kim Looringh-van Beeck

+44 20 3422 0208

Singer Capital Markets (Joint broker)

​+44 20 7496 3000

Charles Leigh-Pemberton

Oliver Platts

Peel Hunt (Joint broker)

+44 20 7418 8900

Ed Allsopp

Tom Graham

  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKNBBCBDDNDD
Date   Source Headline
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.